Form 8-K EUDA Health Holdings For: Jan 25

January 31, 2023 4:06 PM EST

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
0001847846 false 0001847846 2023-01-25 2023-01-25 0001847846 LAX:OrdinarySharesMember 2023-01-25 2023-01-25 0001847846 LAX:RedeemableWarrantsMember 2023-01-25 2023-01-25 iso4217:USD xbrli:shares iso4217:USD xbrli:shares






Washington, D.C. 20549


Form 8-K


Current Report

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934


Date of Report (Date of earliest event reported): January 25, 2023


EUDA Health Holdings Limited

(Exact Name of Registrant as Specified in its Charter)


British Virgin Islands   001-40678   n/a

(State or other jurisdiction

of  incorporation)



File Number)


(I.R.S. Employer

Identification No.)


1 Pemimpin Drive #12-07

One Pemimpin Singapore 576151

(Address of Principal Executive Offices and Zip Code)


Registrant’s telephone number, including area code: +65 6268 6821



(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Securities registered pursuant to Section 12(b) of the Act:


Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Ordinary Shares   EUDA   NASDAQ Stock Market LLC
Redeemable Warrants   EUDAW   NASDAQ Stock Market LLC


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).


Emerging growth company


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.







Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


Effective January 25, 2023, Kim Hing Chan resigned as a member of the Board of Directors (the “Board”) of EUDA Health Holdings Limited (the “Registrant”). The resignation of Kim Hing Chan, a member of the Board’s Compensation Committee, was not the result of any disagreement with the Registrant, the Registrant’s management or the Board.







Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Dated: January 31, 2023


  EUDA Health Holdings Limited
  By: /s/ Wei Wen Kelvin Chen
  Name: Wei Wen Kelvin Chen
  Title: Chief Executive Officer








IDEA: R1.htm

IDEA: form8-k_htm.xml

IDEA: Financial_Report.xlsx

IDEA: FilingSummary.xml

IDEA: MetaLinks.json

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

SEC Filings